Migraine News and Research

Latest Migraine News and Research

Health Canada announces labelling update for Cipralex

Health Canada is informing Canadians of a labelling update for the prescription drug Cipralex (the brand name of the drug escitalopram) regarding a dose-related risk of abnormal heart rhythms. Cipralex is used to treat depression and belongs to a family of drugs known as Selective Serotonin Reuptake Inhibitors (SSRIs).

7 May 2012

MAP Pharmaceuticals first quarter net loss increases to $17.8 million

MAP Pharmaceuticals, Inc. today announced financial results for the first quarter ended March 31, 2012.

5 May 2012

Foods rich in omega-3 fatty acids linked with lower blood beta-amyloid levels

A new study suggests that eating foods that contain omega-3 fatty acids, such as fish, chicken, salad dressing and nuts, may be associated with lower blood levels of a protein related to Alzheimer's disease and memory problems.

3 May 2012

Electrical brain stimulation technology may prevent migraine attacks

Migraine pain sits at the upper end of the typical pain scale - an angry-red section often labeled "severe." At this intensity, pain is debilitating. Yet many sufferers do not get relief from - or cannot tolerate - over-the-counter and commonly prescribed pain medications.

2 May 2012

HealthClips Rx patient education app now available in iTunes

Milner-Fenwick, Inc. and Preventice, Inc. announced today that the HealthClips Rx patient education app is now available in iTunes. To familiarize health care providers with this interactive patient education model, Milner-Fenwick and Preventice are offering a free, two-week trial to physicians and care providers.

2 May 2012

Only few clinical trials are being conducted to test drugs in pediatric patients

Although children are more likely than adults to suffer from many diseases, few clinical trials are being conducted to test drugs in pediatric patients, according to a study to be presented Saturday, April 28, at the Pediatric Academic Societies (PAS) annual meeting in Boston.

30 Apr 2012

Rochester researcher to continue MS study

A Rochester, New York, researcher will receive a $263,622 grant to continue his study of injury to brain cell connections (synapses) in multiple sclerosis (MS) through the American Brain Foundation (formerly the American Academy of Neurology Foundation) and the National Multiple Sclerosis Society Clinician-Scientist Development Award.

27 Apr 2012

HMS researcher receives $130,000 to conduct epilepsy study

A researcher from Beth Israel Deaconess Medical Center and Harvard Medical School is receiving $130,000 to conduct further research on memory dysfunction in epilepsy patients through the Susan S. Spencer Clinical Research Training Fellowship.

27 Apr 2012

UCSF researcher to study risk factors and consequences of stroke

A San Francisco researcher is receiving $130,000 for her research studying risk factors and consequences of stroke among different racial/ethnic groups through the AHA/ASA/ABF Lawrence M. Brass, MD, Stroke Research Postdoctoral Fellowship from the American Brain Foundation,(formerly the American Academy of Neurology Foundation), the American Heart Association and the American Stroke Association.

27 Apr 2012

UIC researcher to explore causes of myasthenia gravis

A University of Illinois at Chicago researcher is the recipient of a $240,000 research grant to further explore the causes of myasthenia gravis, a neurologic disease affecting muscles.

27 Apr 2012

Latest AAN/AHS guidelines can help prevent migraine attacks

The latest American Academy of Neurology/American Headache Society Guidelines released this week outline evidence-based and effective treatments that can prevent migraine attacks and lessen their severity.

26 Apr 2012

Botox effect modest in migraine prevention: Study

Botox injections have been used in prevention of migraines but new research shows that its effect is only modest. Among chronic sufferers who had at least 15 migraines a month, the treatment prevented, on average, about two headaches a month. Botox was no more effective than some of the most widely prescribed drugs used for migraines when the treatments were compared.

25 Apr 2012

AANF changes name to American Brain Foundation

The American Academy of Neurology Foundation is now the American Brain Foundation. The name change is part of an overall re-branding campaign as the organization repositions itself to become the world's leader in raising money for research to cure brain diseases, such as Alzheimer's disease, stroke, Parkinson's disease, autism, and epilepsy.

25 Apr 2012

Preventive treatments can reduce migraine attacks

Research shows that many treatments can help prevent migraine in certain people, yet few people with migraine who are candidates for these preventive treatments actually use them, according to new guidelines issued by the American Academy of Neurology.

24 Apr 2012

Migraine prevention guidelines released

The latest migraine prevention guidelines will be presented at the American Academy of Neurology's annual meeting in New Orleans and published simultaneously in the journal Neurology.

24 Apr 2012

Botox injections may improve frequency of chronic daily and migraine headaches

Although botulinum toxin A injections are U.S. Food and Drug Administration approved for preventive treatment for chronic migraines, a review and analysis of previous studies finds a small to modest benefit for patients with chronic migraine headaches and chronic daily headaches, although botox injections were not associated with greater benefit than placebo for preventing episodic migraine or chronic tension-type headaches, according to an article in the April 25 issue of JAMA.

24 Apr 2012

‘Brain freeze’ provides clue to migraine cause and therapy

According to latest reports by researchers the headache that is caused by eating something cold like an ice cream, may be caused by a sudden change in brain blood flow. The U.S. team of researchers add that this study may show targets to treat other, more troubling forms of headache such as migraine.

23 Apr 2012

Enrollment complete for In-tunnel SeptRx European PFO Trial in Europe

SeptRx, an emerging medical device company that has developed the SeptRx Intrapocket PFO Occluder (IPO), reported today that it has completed enrollment for its "InterSEPT" (In-tunnel SeptRx European PFO Trial) clinical trial in Europe, and has entered into a partnership with CoRRect Medical GmbH for commercial distribution in Germany and Switzerland of the SeptRx IPO.

23 Apr 2012

Brain freeze may share common mechanism with other types of headaches

'Brain freeze' is a nearly universal experience—almost everyone has felt the near-instantaneous headache brought on by a bite of ice cream or slurp of ice-cold soda on the upper palate. However, scientists are still at a loss to explain this phenomenon. Since migraine sufferers are more likely to experience brain freeze than people who don't have this often-debilitating condition, brain freeze may share a common mechanism with other types of headaches, including those brought on by the trauma of blast-related combat injuries in soldiers.

23 Apr 2012

Study: 1 in 26 may develop epilepsy at some point in life

A landmark study from the Institute of Medicine (IOM) reports that your chance of developing epilepsy at some point in your life is one in 26. Onset is highest in children and older adults. But epilepsy knows no boundaries—it can strike at any age and across all socio-economic levels and ethnicities. There is no known cure and one-third of people with epilepsy have treatment-resistant or refractory epilepsy.

17 Apr 2012